Resmed Overview
Resmed Target Price
Analysts' 12-month price predictions for RMD.
Get informed when a big investor buys or sells
+ FollowShare Price
$209.63
Average Target Price
$253.20
20.8% upside
20.8% upside5 analysts in the last 4 months
High: $290 | Low: $225
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-22 | KeyBanc | $266 | 26.9% upside |  |
| 2026-06-17 | Morgan StanleyDavid Bailey | $230 | 9.7% upside | |
| 2026-05-01 | Robert W. Baird | $225 | 7.3% upside | |
| 2026-04-27 | KeyBanc | $290 | 38.3% upside | |
| 2026-04-13 | Evercore ISIAnthony Petrone | $255 | 21.6% upside | |
| 2026-01-30 | Robert W. Baird | $281 | 34% upside | |
| 2026-01-30 | RBC CapitalCraig Wong-Pan | $314 | 49.8% upside | |
| 2026-01-30 | Stifel Nicolaus | $265 | 26.4% upside | |
| 2026-01-30 | KeyBancBrett Fishbin | $302 | 44.1% upside | |
| 2026-01-30 | Piper Sandler | $275 | 31.2% upside | |
| 2025-12-18 | Stifel NicolausJonathan Block | $260 | 24% upside | |
| 2025-12-16 | Robert W. Baird | $275 | 31.2% upside | |
| 2025-12-12 | UBSMarcus Curley | $345 | 64.6% upside | |
| 2025-11-03 | Robert W. Baird | $300 | 43.1% upside | |
| 2025-10-31 | KeyBancBrett Fishbin | $299 | 42.6% upside | |
| 2025-10-31 | Morgan StanleyDavid Bailey | $305 | 45.5% upside | |
| 2025-10-21 | Morgan Stanley | $304 | 45% upside | |
| 2025-10-13 | Wells Fargo | $280 | 33.6% upside | |
| 2025-05-20 | Morgan StanleyDavid Bailey | $286 | 36.4% upside | |
| 2025-04-24 | KeyBancBrett Fishbin | $274 | 30.7% upside | |
| 2025-04-16 | Mizuho SecuritiesAnthony Petrone | $265 | 26.4% upside | |
| 2025-03-05 | Stifel Nicolaus | $240 | 14.5% upside | |
| 2025-01-31 | Piper SandlerAdam Maeder | $260 | 24% upside | |
| 2024-12-12 | Stifel NicolausJonathan Block | $250 | 19.3% upside | |
| 2024-10-01 | RBC CapitalCraig Wong-Pan | $224 | 6.9% upside | |
| 2024-09-23 | Robert W. BairdJoe Vruwink | $280 | 33.6% upside | |
| 2024-09-18 | Wolfe ResearchMike Polark | $180 |  14.1% downside | |
| 2024-04-10 | RBC CapitalCraig Wong-Pan | $187 | 10.8% downside | |
| 2024-04-01 | Stifel NicolausMike Matson | $224 | 6.9% upside | |
| 2023-10-27 | OppenheimerSuraj Kalia | $175 | 16.5% downside | |
| 2023-09-06 | NeedhamMike Matson | $180 | 14.1% downside | |
| 2022-06-20 | RBC CapitalCraig Wong-Pan | $244 | 16.4% upside | |
| 2022-04-29 | RBC Capital | $233 | 11.1% upside | |
| 2021-10-14 | OppenheimerSuraj Kalia | $312 | 48.8% upside | |
| 2021-08-04 | Morgan StanleySean Laaman | $250 | 19.3% upside | |
| 2021-07-28 | JefferiesAnthony Petrone | $240 | 14.5% upside | |